Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Longwall Venture Partners

Founders David Denny Matthew Frohn Michael Penington

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 43
Average round size
info
The average size of a deal this fund participated in
$6M
Portfolio companies 26
Rounds per year 3.31
Lead investments 8
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.40
Key employees 5

Areas of investment

  • Biotechnology
  • Health Care
  • Medical Device
  • Manufacturing
  • Machinery Manufacturing
Summary

In 2011 was created Longwall Venture Partners, which is appeared as VC. The company was established in Europe in United Kingdom. The main department of described VC is located in the Harwell.

The current fund was established by David Denny, Matthew Frohn, Michael Penington. Besides them, we counted 5 critical employees of this fund in our database.

The usual things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in 2-6 deals per year. The real fund results show that this VC is 19 percentage points more often commits exit comparing to other companies. The top activity for fund was in 2018.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Longwall Venture Partners, startups are often financed by Innovate UK, The FSE Group, Oxford Technology Management. The meaningful sponsors for the fund in investment in the same round are Oxford Technology Management, Wren Capital, UK Innovation & Science Seed Fund. In the next rounds fund is usually obtained by IQ Capital, UK Innovation & Science Seed Fund, The FSE Group.

Among the most popular portfolio startups of the fund, we may highlight Wayland Additive, Momentum Bioscience, Azellon Cell Therapeutics. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most successful fund investment fields, there are Manufacturing, Electronics. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Longwall Venture Partners:
Typical Co-investors
Longwall Venture Partners is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Longwall Venture Partners:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Avonlea Capital District of Columbia, United States, Washington
Canon IT Solutions Japan, Tokyo
CSL Capital Management Houston, Texas, United States
Dingxiang Technologies Beijing, Beijing, China
FAM Capital Partners -
Magyar Telekom Budapest, Hungary
Middle East Internet Group Berlin, Berlin, Germany
NetApp Excellerator Bengaluru, India, Karnataka
Pareto Securities -
Velocity Financial Group Massachusetts, United States, Wakefield

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Wayland Additive

3D Printing
Machinery Manufacturing
Manufacturing
$5M23 Jan 2024 London, England, United Kingdom

Lightcast Discovery

Biotechnology
$52M17 Aug 2023 Cambridge, Cambridgeshire, United Kingdom

Wayland Additive

3D Printing
Machinery Manufacturing
Manufacturing
$6M19 Apr 2023 London, England, United Kingdom

Caristo Diagnostics

Biopharma
Biotechnology
Health Care
Health Diagnostics
Medical
Medical Device
$16M17 Apr 2023 Oxford, England, United Kingdom

MicrofluidX

Biotechnology
Medical Device
$4M08 Dec 2022 London, England, United Kingdom

Helio

$4M02 Mar 2022 -

Closed Loop Medicine

Health Care
Pharmaceutical
Therapeutics
$17M03 Nov 2021 London, England, United Kingdom

Kinomica

Biopharma
Biotechnology
$5M14 Dec 2020 United Kingdom, England

Caristo Diagnostics

Biopharma
Biotechnology
Health Care
Health Diagnostics
Medical
Medical Device
$10M26 Nov 2020 Oxford, England, United Kingdom

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Longwall Venture Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 43
Average round size 6M
Rounds per year 3.31
Peak activity year 2019
Lead investments 8
Follow on index 0.40
Group Appearance index 0.95

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Wayland Additive

3D Printing
Machinery Manufacturing
Manufacturing
$5M23 Jan 2024 London, England, United Kingdom

Lightcast Discovery

Biotechnology
$52M17 Aug 2023 Cambridge, Cambridgeshire, United Kingdom

Wayland Additive

3D Printing
Machinery Manufacturing
Manufacturing
$6M19 Apr 2023 London, England, United Kingdom

Caristo Diagnostics

Biopharma
Biotechnology
Health Care
Health Diagnostics
Medical
Medical Device
$16M17 Apr 2023 Oxford, England, United Kingdom

MicrofluidX

Biotechnology
Medical Device
$4M08 Dec 2022 London, England, United Kingdom

Helio

$4M02 Mar 2022 -

Closed Loop Medicine

Health Care
Pharmaceutical
Therapeutics
$17M03 Nov 2021 London, England, United Kingdom

Kinomica

Biopharma
Biotechnology
$5M14 Dec 2020 United Kingdom, England

Caristo Diagnostics

Biopharma
Biotechnology
Health Care
Health Diagnostics
Medical
Medical Device
$10M26 Nov 2020 Oxford, England, United Kingdom
Crunchbase icon

Content report

The following text will be sent to our editors: